{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:25:55Z","timestamp":1787243155902,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,11,19]],"date-time":"2014-11-19T00:00:00Z","timestamp":1416355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00109-014-1223-5","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T08:16:46Z","timestamp":1416557806000},"page":"1229-1234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["p53 in liver pathologies\u2014taking the good with the bad"],"prefix":"10.1007","volume":"92","author":[{"given":"Meital","family":"Charni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Rivlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Molchadsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Aloni-Grinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varda","family":"Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,19]]},"reference":[{"key":"1223_CR1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557\u20132576","journal-title":"Gastroenterology"},{"key":"1223_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2013.12.024","volume":"346","author":"J Ding","year":"2014","unstructured":"Ding J, Wang H (2014) Multiple interactive factors in hepatocarcinogenesis. Cancer Lett 346:17\u201323","journal-title":"Cancer Lett"},{"key":"1223_CR3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1365-2036.2006.03110.x","volume":"24","author":"A Gramenzi","year":"2006","unstructured":"Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, Bernardi M (2006) Review article: alcoholic liver disease\u2014pathophysiological aspects and risk factors. Aliment Pharmacol Ther 24:1151\u20131161","journal-title":"Aliment Pharmacol Ther"},{"key":"1223_CR4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674\u2013687","journal-title":"Nat Rev Cancer"},{"key":"1223_CR5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.metabol.2014.01.011","volume":"63","author":"R Karagozian","year":"2014","unstructured":"Karagozian R, Derdak Z, Baffy G (2014) Obesity-associated mechanisms of hepatocarcinogenesis. Metab Clin Exp 63:607\u2013617","journal-title":"Metab Clin Exp"},{"key":"1223_CR6","first-page":"9217","volume":"20","author":"A Scalera","year":"2014","unstructured":"Scalera A, Tarantino G (2014) Could metabolic syndrome lead to hepatocarcinoma non-alcoholic fatty liver disease? World J Gastroenterol 20:9217\u20139228","journal-title":"World J Gastroenterol"},{"key":"1223_CR7","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","volume":"332","author":"JC Cohen","year":"2011","unstructured":"Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science 332:1519\u20131523","journal-title":"Science"},{"key":"1223_CR8","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley BQ, Calcagno CJ, Harrison SA (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51:1820\u20131832","journal-title":"Hepatology"},{"key":"1223_CR9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3892\/ijo.2013.1829","volume":"42","author":"H Shiraha","year":"2013","unstructured":"Shiraha H, Yamamoto K, Namba M (2013) Human hepatocyte carcinogenesis (review). Int J Oncol 42:1133\u20131138","journal-title":"Int J Oncol"},{"key":"1223_CR10","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","volume":"56","author":"G Baffy","year":"2012","unstructured":"Baffy G, Brunt EM, Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 56:1384\u20131391","journal-title":"J Hepatol"},{"key":"1223_CR11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"1223_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00109-011-0735-5","volume":"89","author":"OD Maddocks","year":"2011","unstructured":"Maddocks OD, Vousden KH (2011) Metabolic regulation by p53. J Mol Med (Berlin, Germany) 89:237\u2013245","journal-title":"J Mol Med (Berlin, Germany)"},{"key":"1223_CR13","first-page":"a001222","volume":"2","author":"DP Lane","year":"2010","unstructured":"Lane DP, Cheok CF, Lain S (2010) p53-based cancer therapy. Cold Spring Harb Perspect Biol 2:a001222","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1223_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","volume":"253","author":"M Hollstein","year":"1991","unstructured":"Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49\u201353","journal-title":"Science"},{"key":"1223_CR15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","volume":"2","author":"KH Vousden","year":"2002","unstructured":"Vousden KH, Lu X (2002) Live or let die: the cell\u2019s response to p53. Nat Rev Cancer 2:594\u2013604","journal-title":"Nat Rev Cancer"},{"key":"1223_CR16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tem.2012.06.007","volume":"23","author":"I Goldstein","year":"2012","unstructured":"Goldstein I, Rotter V (2012) Regulation of lipid metabolism by p53\u2014fighting two villains with one sword. Trends Endocrinol Metab 23:567\u2013575","journal-title":"Trends Endocrinol Metab"},{"key":"1223_CR17","author":"I Goldstein","year":"2011","unstructured":"Goldstein I, Ezra O, Rivlin N, Molchadsky A, Madar S, Goldfinger N, Rotter V (2011) p53, a novel regulator of lipid metabolism pathways. J Hepatol. doi: 10.1016\/j.jhep.2011.08.022","journal-title":"J Hepatol"},{"key":"1223_CR18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/carcin\/bgs318","volume":"34","author":"I Goldstein","year":"2013","unstructured":"Goldstein I, Rivlin N, Shoshana OY, Ezra O, Madar S, Goldfinger N, Rotter V (2013) Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53. Carcinogenesis 34:190\u2013198","journal-title":"Carcinogenesis"},{"key":"1223_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2049-3002-1-9","volume":"1","author":"I Goldstein","year":"2013","unstructured":"Goldstein I, Yizhak K, Madar S, Goldfinger N, Ruppin E, Rotter V (2013) p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production. Cancer Metab 1:9","journal-title":"Cancer Metab"},{"key":"1223_CR20","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/hep.26233","volume":"57","author":"S Kurinna","year":"2013","unstructured":"Kurinna S, Stratton SA, Coban Z, Schumacher JM, Grompe M, Duncan AW, Barton MC (2013) p53 regulates a mitotic transcription program and determines ploidy in normal mouse liver. Hepatology 57:2004\u20132013","journal-title":"Hepatology"},{"key":"1223_CR21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.freeradbiomed.2008.01.011","volume":"44","author":"B Liu","year":"2008","unstructured":"Liu B, Chen Y, St Clair DK (2008) ROS and p53: a versatile partnership. Free Radic Biol Med 44:1529\u20131535","journal-title":"Free Radic Biol Med"},{"key":"1223_CR22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12072-009-9158-6","volume":"3","author":"P Muriel","year":"2009","unstructured":"Muriel P (2009) Role of free radicals in liver diseases. Hepatol Int 3:526\u2013536","journal-title":"Hepatol Int"},{"key":"1223_CR23","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.3748\/wjg.v12.i38.6198","volume":"12","author":"A Panasiuk","year":"2006","unstructured":"Panasiuk A, Dzieciol J, Panasiuk B, Prokopowicz D (2006) Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease. World J Gastroenterol 12:6198\u20136202","journal-title":"World J Gastroenterol"},{"key":"1223_CR24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bbrc.2008.06.006","volume":"373","author":"CS Lieber","year":"2008","unstructured":"Lieber CS, Leo MA, Wang X, Decarli LM (2008) Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function. Biochem Biophys Res Commun 373:246\u2013252","journal-title":"Biochem Biophys Res Commun"},{"key":"1223_CR25","doi-asserted-by":"crossref","first-page":"20571","DOI":"10.1074\/jbc.M400884200","volume":"279","author":"N Yahagi","year":"2004","unstructured":"Yahagi N, Shimano H, Matsuzaka T, Sekiya M, Najima Y, Okazaki S, Okazaki H, Tamura Y, Iizuka Y, Inoue N et al (2004) p53 involvement in the pathogenesis of fatty liver disease. J Biol Chem 279:20571\u201320575","journal-title":"J Biol Chem"},{"key":"1223_CR26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jhep.2012.05.013","volume":"57","author":"K Tomita","year":"2012","unstructured":"Tomita K, Teratani T, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K, Nishiyama K, Mataki N, Irie R, Minamino T et al (2012) p53\/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice. J Hepatol 57:837\u2013843","journal-title":"J Hepatol"},{"key":"1223_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbrc.2004.09.213","volume":"325","author":"G Pani","year":"2004","unstructured":"Pani G, Fusco S, Colavitti R, Borrello S, Maggiano N, Cravero AA, Farre SM, Galeotti T, Koch OR (2004) Abrogation of hepatocyte apoptosis and early appearance of liver dysplasia in ethanol-fed p53-deficient mice. Biochem Biophys Res Commun 325:97\u2013100","journal-title":"Biochem Biophys Res Commun"},{"key":"1223_CR28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2010.08.007","volume":"54","author":"Z Derdak","year":"2011","unstructured":"Derdak Z, Lang CH, Villegas KA, Tong M, Mark NM, de la Monte SM, Wands JR (2011) Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. J Hepatol 54:164\u2013172","journal-title":"J Hepatol"},{"key":"1223_CR29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2012.11.042","volume":"58","author":"Z Derdak","year":"2013","unstructured":"Derdak Z, Villegas KA, Harb R, Wu AM, Sousa A, Wands JR (2013) Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. J Hepatol 58:785\u2013791","journal-title":"J Hepatol"},{"key":"1223_CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","volume":"13","author":"RH Houtkooper","year":"2012","unstructured":"Houtkooper RH, Pirinen E, Auwerx J (2012) Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13:225\u2013238","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1223_CR31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1053\/jhep.2003.50368","volume":"38","author":"JE Yeon","year":"2003","unstructured":"Yeon JE, Califano S, Xu J, Wands JR, De La Monte SM (2003) Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver. Hepatology 38:703\u2013714","journal-title":"Hepatology"},{"key":"1223_CR32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb1111","volume":"6","author":"T Ide","year":"2004","unstructured":"Ide T, Shimano H, Yahagi N, Matsuzaka T, Nakakuki M, Yamamoto T, Nakagawa Y, Takahashi A, Suzuki H, Sone H et al (2004) SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol 6:351\u2013357","journal-title":"Nat Cell Biol"},{"key":"1223_CR33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209\u2013218","journal-title":"J Clin Invest"},{"key":"1223_CR34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1101\/sqb.2008.73.048","volume":"73","author":"V Krizhanovsky","year":"2008","unstructured":"Krizhanovsky V, Xue W, Zender L, Yon M, Hernando E, Lowe SW (2008) Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology. Cold Spring Harb Symp Quant Biol 73:513\u2013522","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"1223_CR35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2013.03.020","volume":"153","author":"A Lujambio","year":"2013","unstructured":"Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V et al (2013) Non-cell-autonomous tumor suppression by p53. Cell 153:449\u2013460","journal-title":"Cell"},{"key":"1223_CR36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445:656\u2013660","journal-title":"Nature"},{"key":"1223_CR37","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8191284","volume":"264","author":"F Aguilar","year":"1994","unstructured":"Aguilar F, Harris CC, Sun T, Hollstein M, Cerutti P (1994) Geographic variation of p53 mutational profile in nonmalignant human liver. Science 264:1317\u20131319","journal-title":"Science"},{"key":"1223_CR38","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/sj.onc.1210279","volume":"26","author":"SP Hussain","year":"2007","unstructured":"Hussain SP, Schwank J, Staib F, Wang XW, Harris CC (2007) TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26:2166\u20132176","journal-title":"Oncogene"},{"key":"1223_CR39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1053\/j.gastro.2010.11.034","volume":"140","author":"HG Woo","year":"2011","unstructured":"Woo HG, Wang XW, Budhu A, Kim YH, Kwon SM, Tang ZY, Sun Z, Harris CC, Thorgeirsson SS (2011) Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology 140:1063\u20131070","journal-title":"Gastroenterology"},{"key":"1223_CR40","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.ejca.2012.03.001","volume":"48","author":"J Liu","year":"2012","unstructured":"Liu J, Ma Q, Zhang M, Wang X, Zhang D, Li W, Wang F, Wu E (2012) Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis. Eur J Cancer 48:2328\u20132338","journal-title":"Eur J Cancer"},{"key":"1223_CR41","first-page":"260","volume":"2","author":"P Zhan","year":"2013","unstructured":"Zhan P, Ji YN, Yu LK (2013) TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis. Hepatobiliary Surg Nutr 2:260\u2013265","journal-title":"Hepatobiliary Surg Nutr"},{"key":"1223_CR42","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.febslet.2014.02.011","volume":"588","author":"R Aloni-Grinstein","year":"2014","unstructured":"Aloni-Grinstein R, Shetzer Y, Kaufman T, Rotter V (2014) p53: the barrier to cancer stem cell formation. FEBS Lett 588:2580\u20132589","journal-title":"FEBS Lett"},{"key":"1223_CR43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cell.2014.05.051","volume":"158","author":"DF Tschaharganeh","year":"2014","unstructured":"Tschaharganeh DF, Xue W, Calvisi DF, Evert M, Michurina TV, Dow LE, Banito A, Katz SF, Kastenhuber ER, Weissmueller S et al (2014) p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. Cell 158:579\u2013592","journal-title":"Cell"},{"key":"1223_CR44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng0195-41","volume":"9","author":"H Ueda","year":"1995","unstructured":"Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G (1995) Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9:41\u201347","journal-title":"Nat Genet"},{"key":"1223_CR45","first-page":"6012","volume":"55","author":"XW Wang","year":"1995","unstructured":"Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH, Harris CC (1995) Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 55:6012\u20136016","journal-title":"Cancer Res"},{"key":"1223_CR46","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/carcin\/bgs135","volume":"33","author":"DA Gouas","year":"2012","unstructured":"Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD et al (2012) TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis 33:1219\u20131224","journal-title":"Carcinogenesis"},{"key":"1223_CR47","doi-asserted-by":"crossref","first-page":"14451","DOI":"10.1074\/jbc.M113.460840","volume":"288","author":"J Jin","year":"2013","unstructured":"Jin J, Iakova P, Jiang Y, Lewis K, Sullivan E, Jawanmardi N, Donehower L, Timchenko L, Timchenko NA (2013) Transcriptional and translational regulation of C\/EBPbeta-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1alpha proteins at the early and late stages of liver cancer. J Biol Chem 288:14451\u201314462","journal-title":"J Biol Chem"},{"key":"1223_CR48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","volume":"18","author":"RG Jones","year":"2005","unstructured":"Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18:283\u2013293","journal-title":"Mol Cell"},{"key":"1223_CR49","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1006\/bbrc.2001.5627","volume":"287","author":"K Imamura","year":"2001","unstructured":"Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H (2001) Cell cycle regulation via p53 phosphorylation by a 5\u2032-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun 287:562\u2013567","journal-title":"Biochem Biophys Res Commun"},{"key":"1223_CR50","author":"Q Huang","year":"2014","unstructured":"Huang Q, Li J, Xing J, Li W, Li H, Ke X, Zhang J, Ren T, Shang Y, Yang H et al (2014) CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway. J Hepatol DOI. doi: 10.1016\/j.jhep.2014.04.035","journal-title":"J Hepatol DOI"},{"key":"1223_CR51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M (2009) The first 30 years of p53: growing ever more complex. Nat Rev Cancer 9:749\u2013758","journal-title":"Nat Rev Cancer"},{"key":"1223_CR52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358:15\u201316","journal-title":"Nature"},{"key":"1223_CR53","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199205143262008","volume":"326","author":"AJ Levine","year":"1992","unstructured":"Levine AJ (1992) The p53 tumor-suppressor gene. N Engl J Med 326:1350\u20131352","journal-title":"N Engl J Med"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-014-1223-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-014-1223-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-014-1223-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T13:35:54Z","timestamp":1566048954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-014-1223-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,19]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1223"],"URL":"https:\/\/doi.org\/10.1007\/s00109-014-1223-5","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,19]]}}}